Physician profile
Peter Moyer
NPI 1811167125
$25,989.77
in general payments reported to CMS, 2019-2025
44 companies · $10K in 2025
The $10K reported for 2025 was more than what 96% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,782 · 2020: $1,712 · 2021: $6,366 · 2022: $4,344 · 2023: $1,285 · 2024: $218 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $5,600 · Travel and Lodging: $1,806 · Food and Beverage: $1,733 · Royalty Or License: $1,583 · Consulting Fee: $1,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $5,600.00 |
| Travel and Lodging | $1,805.97 |
| Food and Beverage | $1,732.63 |
| Royalty Or License | $1,583.30 |
| Consulting Fee | $1,063.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| In2bones USA, LLC | $8,083.11 | 2019-2022 | |
| Convatec INC. | $5,674.40 | 2023-2025 | |
| Linvatec Corporation | $4,716.41 | 2023-2025 | Colink 2, Biobrace 23mm, I2b Rapid Set, 10g |
| Arthrex, INC. | $2,870.40 | 2022 | |
| Polarityte, INC. | $1,316.84 | 2019-2021 | |
| Misonix INC | $800.00 | 2019 | |
| Epsfl, LLC | $333.62 | 2023 | |
| Janssen Pharmaceuticals, INC | $306.43 | 2021-2022 | |
| Aroa Biosurgery Incorporated | $275.68 | 2024-2025 | |
| Tricoast Surgical Solutions LLC | $155.67 | 2022-2024 | |
| Paratek Pharmaceuticals, INC. | $127.87 | 2021-2024 | Nuzyra |
| Mimedx Group, INC. | $126.29 | 2025 | |
| Stability Biologics, LLC | $124.86 | 2022 | |
| Abbott Laboratories | $108.01 | 2023-2025 | Proclaim |
| Boehringer Ingelheim Pharmaceuticals, INC. | $99.26 | 2019 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $98.74 | 2020-2023 | Stravix, Grafix Pl, Pico 14 |
| Horizon Therapeutics Plc | $94.78 | 2020-2023 | Krystexxa |
| Abbvie INC. | $73.67 | 2022-2025 | |
| Amgen INC. | $55.75 | 2025 | Krystexxa |
| Averitas Pharma INC. | $50.29 | 2023-2024 | Qutenza |
| Organogenesis INC. | $47.39 | 2022 | |
| Integra Lifesciences Corporation | $33.74 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Reprise Biomedical, INC. | $33.22 | 2024 | Miro3d |
| Nevro Corp. | $31.68 | 2022-2023 | Senza |
| Paragon 28, INC. | $30.31 | 2023 | Gorilla |
| Biocomposites INC | $28.33 | 2025 | Stimulan |
| Next Science LLC | $27.71 | 2023 | Xperience, Blastx, Surgx |
| Bioventus LLC | $22.11 | 2021 | |
| Urgo Medical North America, LLC | $20.08 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Zimvie INC. | $19.55 | 2022 | |
| Wright Medical Technology, INC. | $17.67 | 2020 | |
| Lifenet Health | $16.73 | 2025 | Theragenesis Wound Matrix |
| Orpyx Medical Technologies US INC. | $16.53 | 2022 | |
| Sebela Pharmaceuticals INC. | $16.08 | 2022 | |
| Globus Medical, INC. | $15.72 | 2025 | Senza |
| Kci USA, INC. | $15.09 | 2020 | |
| Solventum Corporation | $14.70 | 2024 | Activ.A.C. |
| Avita Medical Americas, LLC | $14.25 | 2025 | Cohealyx, Permeaderm, Recell |
| Zimmer Biomet Holdings, INC. | $13.73 | 2019 | |
| Baxter Healthcare | $13.68 | 2024 | Perclot |
| Merck Sharp & Dohme LLC | $12.97 | 2019 | |
| Cook Medical LLC | $12.53 | 2021 | |
| Cashflow Solutions, LLC | $12.16 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Musculoskeletal Transplant Foundation INC. | $11.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Moyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.